2012•Journal of Clinical Medicine in PracticeRequires access

Efficacy of insulin glargine combined with acarbose in the treatment of newly-diagnosed type 2 diabetes

Jian Guo

Open publisher page 0 citations

Abstract

Objective To discuss the efficacy of insulin glargine combined with acarbose in newly-diagnosed patients with type 2 diabetes.Methods Fifty-four newly-diagnosed patients with type 2 diabetes received insulin glargine combined with acarbose for 12 weeks.After treatment,the fasting blood glucose(FBG),postprandial 2 hours blood glucose(P2hBG),hemoglobin A1c(HbA1c) and the incidence rate of the hypoglycemia were compared.Results After treatment of 12 weeks,FBG,P2hBG and HbA1c were effectively controlled within acceptable levels in all patients.Meanwhile the incidence rate of the hypoglycemia was very lower.There were no obvious adverse reactions.Conclusion For the newly-diagnosed patients with type 2 diabetes,insulin glargine combined with acarbose is a safe and effective scheme.

About this research paper

What this paper is about

Objective To discuss the efficacy of insulin glargine combined with acarbose in newly-diagnosed patients with type 2 diabetes.Methods Fifty-four newly-diagnosed patients with type 2 diabetes received insulin glargine combined with acarbose for 12 weeks.After treatment,the fasting blood glucose(FBG),postprandial 2 hours blood glucose(P2hBG),hemoglobin A1c(HbA1c) and the incidence rate of the hypoglycemia were compared.Results After treatment of 12 weeks,FBG,P2hBG and HbA1c were effectively controlled within acceptable levels in all patients.Meanwhile the incidence rate of the hypoglycemia was very lower.There were no obvious adverse reactions.Conclusion For the newly-diagnosed patients with type 2 diabetes,insulin glargine combined with acarbose is a safe and effective scheme.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To discuss the efficacy of insulin glargine combined with acarbose in newly-diagnosed patients with type 2 diabetes.Methods Fifty-four newly-diagnosed patients with type 2 diabetes received insulin glargine combined with acarbose for 12 weeks.After treatment,the fasting blood glucose(FBG),postprandial 2 hours blood glucose(P2hBG),hemoglobin A1c(HbA1c) and the incidence rate of the hypoglycemia were compared.Results After treatment of 12 weeks,FBG,P2hBG and HbA1c were effectively controlled within acceptable levels in all patients.Meanwhile the incidence rate of the hypoglycemia was very lower.There were no obvious adverse reactions.Conclusion For the newly-diagnosed patients with type 2 diabetes,insulin glargine combined with acarbose is a safe and effective scheme.

Key concepts: Acarbose, Medicine, Insulin glargine, Postprandial, Hypoglycemia, Type 2 diabetes, Internal medicine, Hemoglobin

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of insulin glargine combined with acarbose in the treatment of newly-diagnosed type 2 diabetes — Research Paper | ScholarLens